All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes

被引:18
作者
Ahn, J
Joo, CH
Seo, I
Kim, DH
Kim, YK
Lee, H
机构
[1] Univ Ulsan, Coll Med, Dept Microbiol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Dept Anat & Cell Biol, Seoul, South Korea
关键词
coxsackievirus B; cardiomyocyte; cytopathic effect; MTT assay;
D O I
10.1002/jmv.20269
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Coxsackievirus B3 (CVB3) has been identified as a major causative agent of acute and chronic myocarditis, but the involvement of other CVB serotypes in myocarditis has not been investigated. To dissect the pathological properties of different CVB serotypes toward primary cardiomyocytes, we tested their effects on primary cardiornyocyte cultures from neonatal rats. Morphological abnormalities were examined by both light and fluorescence microscopy after Hoechst 33342 staining, and loss of cell viability was estimated by MTT assay. All six CVB serotypes showed a similar degree of severe toxicity toward primary cardiomyocytes. CVB clinical isolates had cytopathic effects (CPEs) similar to those of their respective CVB reference strains. Within 12 days of infection with multiplicities of infection MOI 50, the cells began to experience morphological changes including cell shrinkage, rounding-up, and slight nuclear condensation. The irreversible loss of cell viability was readily observed within 3-5 days following virus infection. These results suggest that all six CVB serotypes induce direct, irreversible toxicity towards cardiomyocytes, which eventually leads to the death of infected cells. These findings indicate that the variations in CVB serotype are not the limiting factor determining the susceptibility of cardiomyocytes to CVB infection. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:290 / 294
页数:5
相关论文
共 37 条
[22]  
MUIR P, 1993, BRIT J BIOMED SCI, V50, P258
[23]   Molecular typing of enteroviruses:: Current status and future requirements [J].
Muir, P ;
Kämmerer, U ;
Korn, K ;
Mulders, MN ;
Pöyry, T ;
Weissbrich, B ;
Kandolf, R ;
Cleator, GM ;
van Loon, AM .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (01) :202-+
[24]   Typing of human enteroviruses by partial sequencing of VP1 [J].
Oberste, MS ;
Maher, K ;
Kilpatrick, DR ;
Flemister, MR ;
Brown, BA ;
Pallansch, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1288-1293
[25]   Isolation of viruses from clinical specimens in microtitre plates with cells inoculated in suspension [J].
ONeill, HJ ;
Russell, JD ;
Wyatt, DE ;
McCaughey, C ;
Coyle, PV .
JOURNAL OF VIROLOGICAL METHODS, 1996, 62 (02) :169-178
[26]  
ROSE NR, 1992, ADV INTERNAL MED, V37, P411
[27]   Enterovirus meningitis in adults [J].
Rotbart, HA ;
Brennan, PJ ;
Fife, KH ;
Romero, JR ;
Griffin, JA ;
McKinlay, MA ;
Hayden, FG .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (04) :896-898
[28]   ENTEROVIRAL INFECTIONS OF THE CENTRAL-NERVOUS-SYSTEM [J].
ROTBART, HA .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (04) :971-981
[29]   Viral meningitis [J].
Rotbart, HA .
SEMINARS IN NEUROLOGY, 2000, 20 (03) :277-292
[30]  
ROTBART HA, 1995, MENINGITIS ENCEPHALI, P271